Preventive efficacy of bulk and nanocurcumin against lead-induced oxidative stress in mice

Biological Trace Element Research

Volumn 152, Issue 1, 2013, Pages 31-40

  Flora, Gagan ^a   Gupta, Deepesh ^a   Tiwari, Archana ^a  

^a Rajiv Gandhi Proudyogiki Vishwavidyalaya   (India)

Author keywords

Curcumin; Lead; Nanocurcumin; Nanoencapsulation; Oxidative stress

Indexed keywords

AMINOLEVULINIC ACID; CURCUMIN; GLUTATHIONE; GLUTATHIONE DISULFIDE; LEAD ACETATE; NANOCURCUMIN; REACTIVE OXYGEN METABOLITE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BIOAVAILABILITY; BLOOD; BLOOD SAMPLING; CHELATION; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; LEAD POISONING; MOUSE; NANOENCAPSULATION; NONHUMAN; OXIDATION; OXIDATIVE STRESS; SOFT TISSUE;

ADMINISTRATION, ORAL; ANALYSIS OF VARIANCE; ANIMALS; BRAIN; CURCUMIN; GLUTATHIONE; GLUTATHIONE DISULFIDE; INJECTIONS, INTRAPERITONEAL; KIDNEY; LEAD; LEAD POISONING; MICE; NANOPARTICLES; ORGANOMETALLIC COMPOUNDS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PORPHOBILINOGEN SYNTHASE; PROTEINS; REACTIVE OXYGEN SPECIES; SULFHYDRYL COMPOUNDS; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

ANIMALIA; MUS;

EID: 84874933958     PISSN: 01634984     EISSN: 15590720     Source Type: Journal    
DOI: 10.1007/s12011-012-9586-3     Document Type: Article

References (49)

1. World Health Organization (1995) BIological indices of lead exposure and body burden. In: IPCS, Inorganic lead, Environmental Health Criteria 118, vol 165. WHO, Geneva, pp 114-118
2. Agency for Toxic Substances and Disease Registry Toxicological profile for lead (2005) Draft for public comment. US Department of Health and Human Services, Public Health Service, Atlanta, pp 43-59
3. Flora SJS, Flora G, Saxena G (2006) Chapter 4 - environmental occurrence, health effects and management of lead poisoning. In: José SC, José S (eds) Lead. Elsevier Science B.V, Amsterdam, pp 158-228
4. Kern M, Wisniewski M, Cabell L, Audesirk G (2000) Inorganic lead and calcium interact positively in activation of calmodulin. Neurotoxicology 21:353-363
5. Sinicropi MS, Amantea D, Caruso A, Saturnino C (2010) Chemical and biological properties of toxic metals and use of chelating agents for the pharmacological treatment of metal poisoning. Arch Toxicol 84:501-520
6. Bressler JP, Goldstein GW (1991) Mechanisms of lead neurotoxicity. Biochem Pharmacol 41(4):479-484
7. US. Food and Drug Agency (FDA) (1990) Provisional tolerable exposure levels for lead. US Public Health Service, Contaminants Team HFF-156, Rockville (memorandum)
8. Murata K, Iwata T, Dakeishi M, Karita K (2009) Lead toxicity: does the critical level of lead resulting in adverse effects differ between adults and children? J Occup Health 51(1):1-12
9. Stoleski S, Karadzinska-Bislimovska J, Stikova E, Risteska-Kuc S, Mijakoski D, Minov J (2008) Adverse effects in workers exposed to inorganic lead. Arh Hig Rada Toksikol 59:19-29
10. Bokara KK, Brown E, McCormick R, Yallapragada PR, Rajanna S, Bettaiya R (2008) Lead-induced increase in antioxidant enzymes and lipid peroxidation products in developing rat brain. Biometals 21:9-16
11. Ercal N, Treeratphan P, Hammond TC, Matthews RH, Grannemann NH, Spitz DR (1996) In vivo indices of oxidative stress in lead-exposed C57BL/6 mice are reduced by treatment with meso-2,3-dimercaptosuccinic acid or N-acetylcysteine. Free Radic Biol Med 21(2):157-161
12. Ahamed M, Siddiqui MK (2007) Low level lead exposure and oxidative stress: current opinions. Clin Chim Acta 383:57-64
13. Pande M, Flora SJ (2002) Lead induced oxidative damage and its response to combined administration of alpha-lipoic acid and succimers in rats. Toxicology 177(2-3):187-196
14. Saxena G, Flora SJ (2004) Lead-induced oxidative stress and hematological alterations and their response to combined administration of calcium disodium EDTA with a thiol chelator in rats. J Biochem Mol Toxicol 18:221-233
15. Flora SJ, Gautam P, Dwivedi N (2012) Dose-dependent effects of ethanol on lead-induced oxidative stress in rats. J Environ Pathol Toxicol Oncol 31:61-73
16. Gurer H, Ercal N (2000) Can antioxidants be beneficial in the treatment of lead poisoning? Free Radic Biol Med 29:927-945
17. Brent J (2005) Critical care toxicology: Diagnosis and management of the critically poisoned patient. Elsevier Mosby, Philadelphia
18. Flora SJ, Mittal M, Mehta A (2008) Heavy metal induced oxidative stress & its possible reversal by chelation therapy. Indian J Med Res 128:501-523
19. Bradberry S, Vale A (2009) A comparison of sodium calcium edetate (edetate calcium disodium) and succimer (DMSA) in the treatment of inorganic lead poisoning. Clin Toxicol (Phila) 47(9):841-858
20. Flora SJ, Pachauri V (2010) Chelation in metal intoxication. Int J Environ Res Public Health 7:2745-2788
21. Moghimi SM, Hunter AC, Murray JC (2001) Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 53:283-318
22. Stolnik S, Illum L, Davis SS (2012) Long circulating microparticulate drug carriers. Adv Drug Deliv Rev 64:290-301
23. Yadav A, Lomash V, Samim M, Flora SJ (2012) Curcumin encapsulated in chitosan nanoparticles: a novel strategy for the treatment of arsenic toxicity. Chem Biol Interact 199:49-61
24. Shukla PK, Khanna VK, Khan MY, Srimal RC (2003) Protective effect of curcumin against lead neurotoxicity in rat. Hum Exp Toxicol 22:653-658
25. Ak T, Gulcin I (2008) Antioxidant and radical scavenging properties of curcumin. Chem Biol Interact 174:27-37
26. Maiti K, Mukherjee K, Gantait A, Saha BP, Mukherjee PK (2007) Curcumin-phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats. Int J Pharm 330:155-163
27. Bisht S, Maitra A (2009) Dextran-doxorubicin/chitosan nanoparticles for solid tumor therapy. Wiley Interdiscip Rev Nanomed Nanobiotechnol 1(4):415-425
28. Katas H, Alpar HO (2006) Development and characterisation of chitosan nanoparticles for siRNA delivery. J Control Release 115(2):216-225
29. El-Demerdash FM, Yousef MI, Radwan FM (2009) Ameliorating effect of curcumin on sodium arsenite-induced oxidative damage and lipid peroxidation in different rat organs. Food Chem Toxicol 47:249-254
30. Socci DJ, Bjugstad KB, Jones HC, Pattisapu JV, Arendash GW (1999) Evidence that oxidative stress is associated with the pathophysiology of inherited hydrocephalus in the H-Tx rat model. Exp Neurol 155:109-117
31. Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82:70-77
32. Jollow DJ, Mitchell JR, Zampaglione N, Gillette JR (1974) Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology 11:151-169
33. Berlin A, Schaller KH (1974) European standardized method for the determination of delta-aminolevulinic acid dehydratase activity in blood. Z Klin Chem Klin Biochem 12:389-390
34. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358
35. Hissin PJ, Hilf R (1976) A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 74:214-226
36. Hu ML (1994) Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol 233:380-385
37. Levine RL, Williams JA, Stadtman ER, Shacter E (1994) Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol 233:346-357
38. Daniel S, Limson JL, Dairam A, Watkins GM, Daya S (2004) Through metal binding, curcumin protects against lead- and cadmium-induced lipid peroxidation in rat brain homogenates and against lead-induced tissue damage in rat brain. J Inorg Biochem 98:266-275
39. Sandhir R, Gill KD (1995) Effect of lead on lipid peroxidation in liver of rats. Biol Trace Elem Res 48:91-97
40. Dairam A, Limson JL, Watkins GM, Antunes E, Daya S (2007) Curcuminoids, curcumin, and demethoxycurcumin reduce lead-induced memory deficits in male Wistar rats. J Agric Food Chem 55:1039-1044
41. Flora SJ, Saxena G, Mehta A (2007) Reversal of lead-induced neuronal apoptosis by chelation treatment in rats: role of reactive oxygen species and intracellular Ca(2+). J Pharmacol Exp Ther 322:108-116
42. Deane R, Bradbury MW (1990) Transport of lead-203 at the blood-brain barrier during short cerebrovascular perfusion with saline in the rat. J Neurochem 54:905-914
43. Moreira EG, Vassilieff I, Vassilieff VS (2001) Developmental lead exposure: behavioral alterations in the short and long term. Neurotoxicol Teratol 23:489-495
44. Flora SJ, Pande M, Mehta A (2003) Beneficial effect of combined administration of some naturally occurring antioxidants (vitamins) and thiol chelators in the treatment of chronic lead intoxication. Chem Biol Interact 145:267-280
45. Gautam P, Flora SJ (2010) Oral supplementation of gossypin during lead exposure protects alteration in heme synthesis pathway and brain oxidative stress in rats. Nutrition 26:563-570
46. Biswas J, Sinha D, Mukherjee S, Roy S, Siddiqi M, Roy M (2010) Curcumin protects DNA damage in a chronically arsenic-exposed population of West Bengal. Hum Exp Toxicol 29:513-524
47. 2-induced renal epithelial (LLC-PK1) cell injury. Free Radic Biol Med 24:49-54
48. Thiyagarajan M, Sharma SS (2004) Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats. Life Sci 74:969-985
49. Agarwal R, Goel SK, Behari JR (2010) Detoxification and antioxidant effects of curcumin in rats experimentally exposed to mercury. J Appl Toxicol 30:457-468